Kingsview Wealth Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Kingsview Wealth Management's EXAS Position: Q1 2024 in Review
Kingsview Wealth Management sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 12,491 shares — an estimated $924K sold.
Kingsview Wealth Management first reported a position in EXAS in Q2 2020 and held it in 11 quarters. The position peaked at $924K in Q4 2023. 626 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.
- Kingsview Wealth Management reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
- Kingsview Wealth Management sold 12,491 Exact Sciences shares in Q1 2024, an estimated $924K.
- Kingsview Wealth Management first reported a position in Exact Sciences in Q2 2020 and held it in 11 quarters.
- Kingsview Wealth Management's Exact Sciences position peaked at $924K in Q4 2023.
- 626 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.
Based on Kingsview Wealth Management's 13F filing for Q1 2024, filed 9 May 2024.